Not every breast cancer behaves the same way, and not every breast cancer responds to the same treatment. This is something patients and families often find confusing when they first hear the term "triple-negative breast cancer" during a diagnosis. It sounds alarming, and the name itself does not explain much. In this blog, we break down what triple-negative breast cancer actually means, why it is treated differently from other types of breast cancer, and what patients in Gurugram, Delhi NCR, and across India should know before starting treatment.
What Does "Triple-Negative" Actually Mean?
Every breast cancer is tested for three receptors on the surface of its cells:
• Estrogen receptor (ER)
• Progesterone receptor (PR)
• HER2 protein
When a tumor tests negative for all three, it is called triple-negative breast cancer (TNBC). This means the cancer is not being driven by hormones and does not overexpress the HER2 protein, which rules out two of the most common and effective treatment options used in other breast cancers: hormone therapy and HER2-targeted therapy.
Why It Needs a Different Treatment Approach
Because TNBC cannot be treated with hormone-blocking drugs or HER2-targeted agents, the treatment plan looks quite different:
✔ Chemotherapy is the backbone of treatment, often used before surgery (neoadjuvant chemotherapy) to shrink the tumor and assess response
✔ Surgery remains essential, whether breast conservation surgery or mastectomy, depending on tumor size and location
✔ immunotherapy has emerged as an important addition for certain TNBC patients, particularly when combined with chemotherapy
✔ Genetic testing (BRCA1/BRCA2) is recommended more often in TNBC, since a meaningful proportion of these cancers are linked to inherited gene mutations
✔ Close monitoring after treatment, since TNBC can behave more aggressively in the first few years following diagnosis
This is why a one-size-fits-all approach does not work. Treatment decisions for TNBC depend heavily on the stage at diagnosis, the patient's overall health, and how the tumor responds to initial chemotherapy.
Is Triple-Negative Breast Cancer More Dangerous?
Many patients ask this, and the honest answer is nuanced. TNBC does tend to grow faster and is more commonly diagnosed in younger women, which is why early detection matters even more. However, "different" does not mean "untreatable." Many patients with TNBC respond very well to chemotherapy, and a strong initial response is actually a positive sign for long-term outcomes. What matters most is timely diagnosis, a well-planned treatment sequence, and consistent follow-up.
Who Should Consider Genetic Counselling?
Since TNBC has a stronger association with BRCA gene mutations compared to other breast cancer subtypes, genetic counselling is often recommended for:
✔ Women diagnosed with TNBC before the age of 60
✔ Patients with a family history of breast or ovarian cancer
✔ Patients considering future pregnancies or with concerns about risk to other family members
Understanding your genetic status can also guide decisions about additional screening for family members and, in some cases, influence surgical choices.
A Word of Reassurance
Hearing the word "triple-negative" can feel overwhelming, especially with so much conflicting information available online. What matters is working with a breast cancer specialist who can walk you through your specific pathology report, discuss the right sequence of chemotherapy and surgery, and explain what your particular diagnosis means for your treatment plan and prognosis. Every patient's biology is different, and treatment should be tailored accordingly.
About Dr. Rohan Khandelwal
Dr. Rohan Khandelwal is a Fellowship-trained Breast Cancer Surgeon from the University of Maryland, USA, currently serving as Principal Consultant, Breast Cancer Surgery, at CK Birla Hospital for Women, Gurugram. With extensive experience in managing all subtypes of breast cancer, including triple-negative disease, he combines evidence-based treatment planning with a patient-centred approach, ensuring every treatment decision is explained clearly to the patient and family. If you or a loved one has recently received a triple-negative breast cancer diagnosis, do not navigate it alone.
Book a consultation with Dr. Rohan Khandelwal today get a clear, personalized treatment plan. Serving patients across Gurugram, Delhi NCR, Noida, and Faridabad.
Frequently Asked Questions
Is triple-negative breast cancer curable?
Yes. Many patients with triple-negative breast cancer, especially when diagnosed early, achieve long-term remission with a combination of chemotherapy and surgery. A strong response to initial chemotherapy is often a positive indicator for long-term outcomes.
Why doesn't hormone therapy work for TNBC?
Hormone therapy blocks estrogen or progesterone from fueling cancer growth. Since triple-negative tumors do not have these receptors, hormone therapy has nothing to target, which is why chemotherapy and, in some cases, immunotherapy are used instead.
Does every TNBC patient need genetic testing?
Not every patient, but it is recommended more often in TNBC than in other breast cancer subtypes, particularly for women diagnosed before age 60 or with a family history of breast or ovarian cancer.
Is TNBC more common in younger women?
TNBC is diagnosed more frequently in younger women and tends to grow faster than hormone-receptor-positive cancers, which is why early evaluation of any new breast lump is important.
